Abstract
Background Reliable ascertainment of cancer recurrence is essential in order to evaluate therapeutic interventions to treat advanced disease. Specification of the timing of cancer recurrence using administrative claims from SEER-Medicare is challenging and has been limited to the use of algorithms based mainly on ICD9 diagnosis codes.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
